universal influenza vaccine (recombinant replication-incompetent adenovirus type 5 vector) (Vaxart)

N/A

Report date: 2025/01/26 17:46:36

Base Information

Drug Nameuniversal influenza vaccine (recombinant replication-incompetent adenovirus type 5 vector) (Vaxart)

Drug Alias Nameinfluenza vaccine (recombinant replication-incompetent Ad5 vector) (Vaxart)universal influenza vaccine (recombinant replication-incompetent Ad5 vector) (Vaxart)

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVaxart Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesVaxart Biosciences Inc

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A